Understanding the Mechanisms of Glucagon-like Peptide-1 (GLP-1) and its Influence on Energy Expenditure
Introduction

GLP-1 and Energy Expenditure: A Complex Relationship
Central vs. Peripheral Actions of GLP-1



Feb 25, 2026Does tirzepatide speed up your metabolism? We explore the 2026 research on its complex effects onenergyexpenditure, fat loss, and more.
Retatrutide: breakthrough… or still too early? Retatrutide is an investigational triple-hormone receptor agonist (GLP-1+ GIP + glucagon) designed to go beyond current metabolic therapies by targeting appetite,energyexpenditure, and liver fat metabolism at the same time.
Strategies for maintaining weight loss afterGLP-1focus on protein-rich nutrition, consistent exercise, and ongoing monitoring.Howmuch does starting weight affectGLP-1before and after results? Starting weightinfluencesabsolute pounds lost but percentage of body weight lost is remarkably consistent across starting weights.
3 days agoLearnhowgut bacteria produce butyrate to trigger naturalGLP-1release, supporting weight loss, brain health, mood regulation, and metabolic balance.
Jan 23, 2025Centrally,GLP-1RAs modulate brain regions controlling appetite, influencing neurotransmitter and peptide release to regulate hunger andenergyexpenditure. Peripherally,GLP-1RAs improve glycemic control by enhancing insulin secretion, reducing glucagon release, delaying gastric emptying, and regulating gut hormones.
The effect size, while modest, suggests a contribution to total dailyenergyexpenditurebeyond caloric restriction alone. Gastric Emptying Delay - Acute administration ofGLP‑1agonists slows the rate at which the stomach empties its contents into the small intestine.
Jun 30, 2025This narrative review explores the mechanisms of GLP-1-mediated glycogen metabolism andenergyexpenditure, particularly in key tissues—pancreas, liver, skeletal muscle, and adipose tissue. In the pancreas,GLP-1enhances insulin secretion and beta-cell function.
Sep 18, 2024The glucagon-like peptide-1 (GLP-1) receptor, known asGLP-1R, is a vital component of the G protein-coupled receptor (GPCR) family and is found primarily on the surfaces of various cell types ...
Background: Glucagon-like peptide1(GLP-1) is a gut hormone that decreases appetite and promotes satiety. Its role inenergymetabolism regulation is still poorly understood.Objective: The aim of the study was to investigate the relation of fasting plasmaGLP-1concentrations to rates ofenergyexpenditure(EE) and substrate oxidation—ie, respiratory quotient (RQ).Design: Forty-six glucose ...
Mar 11, 2026But when coupled withGLP-1drugs that suppress appetite, promotingenergyexpenditurecould lead to therapies that are even more powerful at promoting weight loss.
1 day agoBy turning on the right pathways,GLP-1helps use moreenergy, leading to weight loss. ManagingGLP-1receptors is a key to reaching and keeping a healthy weight.
This page is a summary of:GLP-1is not enough: can glucagon fill theenergyexpendituregap?, Neuroendocrinology, February 2026, Karger Publishers, DOI: 10.1159/000550812.
The purpose of this Review is to discuss the evolution of our understanding ofhowendogenousGLP-1modulatesenergybalance. Specifically, we consider contributions of both central and peripheralGLP-1and propose an integrated model of short-term and long-term control ofenergybalance.
2 days agoWith tirzepatide, weight loss occurs primarily through reduced calorie intake (GLP-1) and improved fat metabolism (GIP). The body takes in lessenergyand processes storedenergymore efficiently. These are powerful mechanisms, but they both operate on the "input" side of theenergybalance equation. Retatrutide adds the "output" side.
Background: Obesity results from an imbalance betweenenergyintake andenergyexpenditure(EE). Glucagon-like peptide-1 receptor (GLP-1R) agonists, reduce weight through appetite suppression but exert minimalinfluenceon EE, potentially limiting long-term efficacy due to adaptive declines in metabolic rate. In contrast, glucagon, traditionally regarded as a glucose counter-regulatory hormone ...
Similar to amylin,GLP-1or its agonists also seem to increaseenergyexpenditureunder some but not all 70 experimental conditions; the effect is dose-dependent and seems to be most robust whenGLP-1is administered centrally. 71 Interestingly, a recent study also indicated thatGLP-1may be involved in the control ofenergyexpenditurein ...
We reviewed clinical trials addressing the effect of glucacon-like peptide1(GLP-1) orGLP-1receptor agonists (GLP-1RA) onenergyexpenditure(EE) in adults.
Howdoes Retatrutide work? Retatrutide activates three hormone receptors thatinfluencemetabolism:GLP-1, GIP, and glucagon receptors. These signals regulate hunger, blood sugar levels, andenergyuse. Is Retatrutide the same as semaglutide or tirzepatide? No. Semaglutide targets theGLP-1pathway while tirzepatide activatesGLP-1and GIP.
Mar 14, 2026Tirzepatide activates two hormone receptors (GLP-1and GIP), while retatrutide activates three (GLP-1, GIP, and glucagon). This additional glucagon receptor activation drives greaterenergyexpenditureand is why researchers consider retatrutide a potential next-generation development in metabolic peptide research.
2 days agoIn depth, these therapiesinfluenceGLP-1metabolic effects by enhancingenergyexpenditureand fat utilization. They promoteGLP-1weight loss through prolonged satiety, reducing overall intake while preserving muscle mass better than calorie cuts alone.
The effect ofGLP-1onenergyexpenditure, representing the other side of theenergybalance equation, has only been investigated in one animal and one human study. 27, 28 In rats a single i.c.v ...
3 days agoHowthe Retatrutide Weight Loss Drug Works in the Body Retatrutide works by interacting with three hormone receptors involved in metabolic regulation. These include:GLP-1receptors, whichinfluenceappetite and blood sugar regulation GIP receptors, which play a role in insulin signaling Glucagon receptors, which mayinfluenceenergyexpenditure
Purpose To investigate the association between fasting glucagon-like peptide1(GLP-1) levels and restingenergyexpenditure(REE), and respiratory quotient (RQ) in overweight and obese adults. Method Study participants were enrolled at the Dietetic and Metabolic Unit, University of Pavia, Italy. Inclusion criteria were age ≥ 25 and ≤ 45 years, and body mass index (BMI) ≥ 25 and ≤ 35 ...
Retatrutide: breakthrough… or still too early? Retatrutide is an investigational triple-hormone receptor agonist (GLP-1+ GIP + glucagon) designed to go beyond current metabolic therapies by targeting appetite,energyexpenditure, and liver fat metabolism at the same time.
5 days agoBothGLP-1and GIPinfluenceenergybalance, butGLP-1has a stronger direct effect on appetite suppression and caloric intake.GLP-1therapies are particularly effective at reducing appetite, which contributes significantly to weight loss.
3 days agoFrequently Asked Questions What drives weight regain followingGLP-1discontinuation? Weight rebound reflects homeostatic defense mechanisms including orexigenic hormone elevation (particularly ghrelin), adaptive thermogenesis reducing restingenergyexpenditure, and enhanced nutrient extraction efficiency.
Mar 11, 2026In the general population, glucagon-like peptide-1 receptor agonists and dual agonists (GLP-1s) have emerged as potent therapies for obesity and related cardiometabolic disorders. Initially developed for type 2 diabetes mellitus,GLP-1simprove glycemic control, promote substantial weight loss, and reduce other cardiometabolic risk factors.
4 days agoIn the medical field, welcome to acronyms.GLP-1stands for glucagon-like peptide-1, and this is a hormone in the body. When we talk aboutGLP-1sorGLP-1agonists as a medication, this means that these are manufactured substances that cause the same action in the body as the naturally occurring hormone would. Kristen Meinzer: AndhowdoGLP-1s...
Retatrutide is a triple agonist (GLP-1, GIP, glucagon receptor), potentially enhancing fat loss,energyexpenditure, and metabolic health. ⚠️ Important: It is NOT FDA-approved and is not commercially available at this time. Exciting science — but we wait for full Phase 3 data and regulatory approval before clinical use.
Learnhowto boostGLP-1naturally with fiber, protein, gut health and lifestyle habits. Discover foods and supplements that support appetite and metabolism.